))
Surprise neuropathological findings in LRRK2 mutation carriers
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on August 25, 2025 23:09 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 494429773 series 3675500
Content provided by International Parkinson and Movement Disorder Society, International Parkinson, and Movement Disorder Society. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by International Parkinson and Movement Disorder Society, International Parkinson, and Movement Disorder Society or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Mutations in LRRK2 are a common cause of familial and sporadic Parkinson’s. Though clinical features resemble typical PD, about half of cases lack Lewy pathology. Doctors Hiroaki Sekiya and Nanna Møller Jensen discuss their recent studies on the neuropathology of LRRK2-PD patients. They dive into their methods and how proximity ligation assays may compare to alpha-synuclein seeding assays in identification of alpha-synuclein oligomers. Together they explain their surprising results on how alpha-synuclein oligomers may be a key early feature in LRRK2-PD.
Read the first article.
Read the second article.
…
continue reading
Read the first article.
Read the second article.
245 episodes
Share
